Does interferon-sparing tenofovir disoproxil fumarate-based therapy have a role in the management of severe acute hepatitis delta superinfection?

Journal of Medical Microbiology

Volumn 61, Issue PART12, 2012, Pages 1780-1783

  Babiker, Zahir Osman Eltahir ^a   Hogan, Celia ^a   Ustianowski, Andrew ^a   Wilkins, Edmund ^a  

^a NORTH MANCHESTER GENERAL HOSPITAL   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

ADEFOVIR; ALPHA INTERFERON; ANTIVIRUS AGENT; FOSCARNET; HEPATITIS B SURFACE ANTIGEN; LAMIVUDINE; PEGINTERFERON; TENOFOVIR DISOPROXIL; VIRUS DNA; VIRUS RNA;

ACUTE DISEASE; ADULT; ARTICLE; CASE REPORT; CHRONIC HEPATITIS; COMORBIDITY; DELTA AGENT HEPATITIS; DISEASE COURSE; DRUG EFFICACY; DRUG INDICATION; HEPATITIS B; HEPATITIS B VIRUS; HEPATITIS DELTA VIRUS; HUMAN; LIVER FUNCTION; MALE; NONHUMAN; PRIORITY JOURNAL; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; SEROLOGY; SUPERINFECTION; TREATMENT OUTCOME; VIRUS HEPATITIS;

ACUTE DISEASE; ADENINE; ANTIVIRAL AGENTS; DNA, VIRAL; DRUG THERAPY, COMBINATION; HEPATITIS B; HEPATITIS D; HEPATITIS DELTA VIRUS; HUMANS; INTERFERONS; LAMIVUDINE; MALE; ORGANOPHOSPHONATES; RNA, VIRAL; SUPERINFECTION; YOUNG ADULT;

EID: 84869439445     PISSN: 00222615     EISSN: None     Source Type: Journal    
DOI: 10.1099/jmm.0.046649-0     Document Type: Article

References (19)

1. Bichko, V., Netter, H. J., Wu, T. T. & Taylor, J. (1994). Pathogenesis associated with replication of hepatitis delta virus. Infect Agents Dis 3, 94-97.
2. Casey, J. L., Brown, T. L., Colan, E. J., Wignall, F. S. & Gerin, J. L. (1993). A genotype of hepatitis D virus that occurs in northern South America. Proc Natl Acad Sci U S A 90, 9016-9020.
3. Hedin, G., Weiland, O., Ljunggren, K., Strö mberg, A., Nordenfelt, E., Hansson, B. G. & Oberg, B. (1987). Treatment of fulminant hepatitis B and fulminant hepatitis B and D coinfection with foscarnet. Prog Clin Biol Res 234, 309-320.
4. Lau, D. T., Doo, E., Park, Y., Kleiner, D. E., Schmid, P., Kuhns, M. C. & Hoofnagle, J. H. (1999). Lamivudine for chronic delta hepatitis. Hepatology 30, 546-549.
5. Le Gal, F., Gault, E., Ripault, M. P., Serpaggi, J., Trinchet, J. C., Gordien, E. & Dé ny, P. (2006). Eighth major clade for hepatitis delta virus. Emerg Infect Dis 12, 1447-1450.
6. Mansour, W., Ducancelle, A., Le Gal, F., Le Guillou-Guillemette, H., Abgueguen, P., Pivert, A., Calè s, P., Gordien, E. & Lunel, F. (2010). Resolution of chronic hepatitis delta after 1 year of combined therapy with pegylated interferon, tenofovir and emtricitabine. J Clin Virol 47, 97-99.
7. Niro, G. A., Ciancio, A., Tillman, H. L., Lagget, M., Olivero, A., Perri, F., Fontana, R., Little, N., Campbell, F. & other authors (2005). Lamivudine therapy in chronic delta hepatitis: a multicentre randomized-controlled pilot study. Aliment Pharmacol Ther 22, 227-232.
8. Niro, G. A., Ciancio, A., Gaeta, G. B., Smedile, A., Marrone, A., Olivero, A., Stanzione, M., David, E., Brancaccio, G. & other authors (2006). Pegylated interferon alpha-2b as monotherapy or in combination with ribavirin in chronic hepatitis delta. Hepatology 44, 713-720.
9. Rasshofer, R., Choi, S., Wö lfl, P., Manneck, K., Weisensee, U. & Roggendorf, M. (1990). Inhibition of HDV RNA replication in vitro by ribavirin and suramin. In Viral Hepatitis and Liver Disease, pp. 659-662. Edited by F. Hollinger, S. Lemon & H. Margolis. Baltimore: Williams & Wilkins.
10. Sheldon, J., Ramos, B., Toro, C., Ríos, P., Martínez-Alarcó n, J., Bottecchia, M., Romero, M., Garcia-Samaniego, J. & Soriano, V. (2008). Does treatment of hepatitis B virus (HBV) infection reduce hepatitis delta virus (HDV) replication in HIV-HBV-HDV-coinfected patients? Antivir Ther 13, 97-102.
11. Smedile, A., Dentico, P., Zanetti, A., Sagnelli, E., Nordenfelt, E., Actis, G. C. & Rizzetto, M. (1981). Infection with the delta agent in chronic HBsAg carriers. Gastroenterology 81, 992-997.
12. Smedile, A., Farci, P., Verme, G., Caredda, F., Cargnel, A., Caporaso, N., Dentico, P., Trepo, C., Opolon, P. & other authors (1982). Influence of delta infection on severity of hepatitis B. Lancet 2, 945-947.
13. Smedile, A., Rosina, F., Saracco, G., Chiaberge, E., Lattore, V., Fabiano, A., Brunetto, M. R., Verme, G., Rizzetto, M. & Bonino, F. (1991). Hepatitis B virus replication modulates pathogenesis of hepatitis D virus in chronic hepatitis D. Hepatology 13, 413-416.
14. Tang, J. R., Hantz, O., Vitvitski, L., Lamelin, J. P., Parana, R., Cova, L., Lesbordes, J. L. & Tré po, C. (1993). Discovery of a novel point mutation changing the HDAg expression of a hepatitis delta virus isolate from Central African Republic. J Gen Virol 74, 1827-1835.
15. Wedemeyer, H., Yurdaydìn, C., Dalekos, G. N., Erhardt, A., Çakaloǧlu, Y., Deǧertekin, H., Gürel, S., Zeuzem, S., Zachou, K. & other authors (2011). Peginterferon plus adefovir versus either drug alone for hepatitis delta. N Engl J Med 364, 322-331.
16. Williams, V., Brichler, S., Radjef, N., Lebon, P., Goffard, A., Hober, D., Fagard, R., Kremsdorf, D., Dé ny, P. & Gordien, E. (2009). Hepatitis delta virus proteins repress hepatitis B virus enhancers and activate the alpha/beta interferon-inducible MxA gene. J Gen Virol 90, 2759-2767.
17. Wolters, L. M., van Nunen, A. B., Honkoop, P., Vossen, A. C., Niesters, H. G., Zondervan, P. E. & de Man, R. A. (2000). Lamivudinehigh dose interferon combination therapy for chronic hepatitis B patients co-infected with the hepatitis D virus. J Viral Hepat 7, 428-434.
18. Yurdaydin, C., Bozkaya, H., Onder, F. O., Sentü rk, H., Karaaslan, H., Akdoǧan, M., Cetinkaya, H., Erden, E., Erkan-Esin, O. & other authors (2008). Treatment of chronic delta hepatitis with lamivudine vs lamivudine + interferon vs interferon. J Viral Hepat 15, 314-321.
19. Yurdaydi{dotless}n, C., Idilman, R., Bozkaya, H. & Bozdayi, A. M. (2010). Natural history and treatment of chronic delta hepatitis. J Viral Hepat 17, 749-756.